Millendo Therapeutics, Inc. MLND
Set alert
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 20.19M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -2.26
- Beta
- 0.48
- Short ratio
- 0.98
- Inst. own
- 37.18%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Jul 2, 2021
- 50-d avg
- 18.86
- 200-d avg
- 25.14
- 1y target
- 2.00
News
-
5 years ago benzinga.com
45 Biggest Movers From Yesterday
Gainers Entera Bio Ltd. (NASDAQ: ENTX) shares surged 44.8% to close at $6.50 on Wednesday after the company reported topline Phase 2 bone mineral density data for EB613.
-
5 years ago benzinga.com
31 Stocks Moving In Wednesday's Mid-Day Session
Gainers Entera Bio Ltd. (NASDAQ: ENTX) shares jumped 58% to $7.09 after the company reported topline Phase 2 bone mineral density data for EB613.
-
5 years ago benzinga.com
26 Stocks Moving in Wednesday's Pre-Market Session
Gainers Acasti Pharma Inc. (NASDAQ: ACST) rose 39% to $0.75 in pre-market trading after jumping 10% on Tuesday. The company reported a narrower FY21 loss.
5 years ago globenewswire.com
Tempest and Millendo Announce Stockholder Approval of Merger
Tempest to Trade on Nasdaq Public Markets Under Ticker “TPST” Tempest to Trade on Nasdaq Public Markets Under Ticker “TPST”
-
5 years ago benzinga.com
Stocks That Hit 52-Week Lows On Friday
Before 10 a.m. ET Friday, 62 stocks made new 52-week lows.
5 years ago businesswire.com
MILLENDO INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Millendo Therapeutics, Inc. - MLND
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Millendo…
5 years ago prnewswire.com
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Millendo Therapeutics, Inc. - MLND
NEW YORK, April 2, 2021 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018 and 2019 ISS Securities Class…
5 years ago businesswire.com
Millendo Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Millendo Therapeutics, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – MLND
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the merger of Millendo Therapeutics, Inc. (NASDAQ: MLND) and Tempest Therapeutics, Inc. is…
5 years ago pulse2.com
MLND Stock Price Falls Over 10% Pre-Market: Why It Happened
The stock price of Millendo Therapeutics Inc (NASDAQ: MLND) fell by over 10% pre-market. This is why it happened.
5 years ago benzinga.com
Tempest Therapeutics To Go Public Via Millendo Therapeutics Merger
Millendo Therapeutics Inc (NASDAQ: MLND) has agreed to merge with privately-held Tempest Therapeutics Inc in an all-stock transaction. The combined company will operate under the Tempest Therapeutics…
5 years ago businesswire.com
Tempest and Millendo Announce Proposed Merger Agreement
SOUTH SAN FRANCISCO, Calif. & ANN ARBOR, Mich.--(BUSINESS WIRE)--Tempest Therapeutics, Inc. (“Tempest”), a privately-held clinical-stage oncology company developing potentially first-in-class…
-
5 years ago benzinga.com
77 Biggest Movers From Yesterday
Gainers Synthetic Biologics, Inc. (NYSE: SYN) shares climbed 100% to close at $1.00 on Tuesday after gaining over 30% on Monday.
6 years ago businesswire.com
Millendo Therapeutics Reports Second Quarter 2020 Operating and Financial Results
Millendo Therapeutics Reports Second Quarter 2020 Operating and Financial Results
6 years ago thelincolnianonline.com
Millendo Therapeutics (NASDAQ:MLND) Cut to “Hold” at Zacks Investment Research
Millendo Therapeutics (NASDAQ:MLND) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued on Tuesday, Zacks.com reports. According to Zacks,…
6 years ago thelincolnianonline.com
Zacks Investment Research Upgrades Millendo Therapeutics (NASDAQ:MLND) to Buy
Zacks Investment Research upgraded shares of Millendo Therapeutics (NASDAQ:MLND) from a hold rating to a buy rating in a report published on Thursday morning, Zacks.com reports. Zacks Investment…
6 years ago thelincolnianonline.com
Millendo Therapeutics Inc (NASDAQ:MLND) Sees Significant Increase in Short Interest
Millendo Therapeutics Inc (NASDAQ:MLND) saw a significant growth in short interest during the month of June. As of June 30th, there was short interest totalling 755,100 shares, a growth of 34.6% from…
6 years ago thelincolnianonline.com
Millendo Therapeutics (NASDAQ:MLND) Trading Down 3.8%
Shares of Millendo Therapeutics Inc (NASDAQ:MLND) dropped 3.8% during trading on Wednesday . The company traded as low as $1.96 and last traded at $1.92, approximately 55,363 shares were traded…
6 years ago businesswire.com
Millendo Therapeutics Provides Corporate and Pipeline Update
Millendo Therapeutics Provides Corporate and Pipeline Update.
6 years ago thelincolnianonline.com
Millendo Therapeutics (NASDAQ:MLND) Shares Gap Down to $2.71
Millendo Therapeutics Inc (NASDAQ:MLND) gapped down before the market opened on Friday . The stock had previously closed at $2.61, but opened at $2.71. Millendo Therapeutics shares last traded at…
6 years ago businesswire.com
Millendo Therapeutics Reports First Quarter 2020 Operating and Financial Results
Millendo Therapeutics Reports First Quarter 2020 Operating and Financial Results
6 years ago reuters.com
Leonardo books first-quarter loss, braces for higher virus impact in second quarter
Italian defence group Leonardo warned on Thursday that the coronavirus outbreak would have a bigger impact in the second quarter, after reporting a net loss in the first three months.
6 years ago investing.com
GBP/CHF Continuation
Forex Analysis by Scott Barkley covering: GBP/CHF. Read Scott Barkley's latest article on Investing.com
6 years ago investing.com
USD/CAD Continuation
Forex Analysis by Scott Barkley covering: USD/CAD. Read Scott Barkley's latest article on Investing.com
6 years ago investing.com
GBP/USD Continuation
Forex Analysis by Scott Barkley covering: . Read Scott Barkley's latest article on Investing.com
6 years ago marketwatch.com
What Are The Best Penny Stocks To Watch This Week? 3 For Your List
Are These On Your List Of Penny Stocks To Watch In May 2020? May 03, 2020 (Penny Stocks via COMTEX) -- Regardless of which names are on your list of penny...
-
7 years ago benzinga.com
Stocks Which Set New 52-Week Low Yesterday, Thurs., Dec. 13, 2018
Stocks Which Set New 52-Week Low Yesterday, Thurs., Dec. 13, 2018